Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2025-12-25 @ 1:32 AM
NCT ID:
NCT02564094
Eligibility Criteria:
Inclusion Criteria:
* Adults at least 18 years of age
* Multiple myeloma (MM), low-grade non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), breast cancer, lung cancer, or ovarian cancer
* Anemia with low erythropoeitin (EPO) levels
Exclusion Criteria:
* Poorly controlled hypertension
* Relevant acute or chronic bleeding requiring therapy within 3 months before study drug
* Treatment with EPO within the last 6 weeks
* Pregnant or breastfeeding females
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02564094
Study Brief:
Protocol Section:
NCT02564094